Escherichia coli D-3-phosphoglycerate dehydrogenase (PGDH) is a homotetrameric enzyme whose activity is allosterically regulated by L-serine, the endproduct of its metabolic pathway. Previous studies have shown that PGDH displays two modes of cooperative interaction. One is between the L-serine binding sites and the other is between the L-serine binding sites and the active sites. Tryptophan 139 participates in an intersubunit contact near the active site catalytic residues. Site-specific mutagenesis of tryptophan 139 to glycine results in the dissociation of the tetramer to a pair of dimers and in the loss of cooperativity in serine binding and between serine binding and inhibition. The results suggest that the magnitude of inhibition of activity at a particular active site is primarily dependent on serine binding to that subunit but that activity can be modulated in a cooperative manner by interaction with adjacent subunits. The disruption of the nucleotide domain interface in PGDH by mutating Trp-139 suggests the potential for a critical role of this interface in the cooperative allosteric processes in the native tetrameric enzyme.
enzyme that is allosterically regulated by the end product of its metabolic pathway, L-serine (1, 2) . The crystal structure of the inhibited enzyme with bound serine (3, PDB # 1PSD) shows that each subunit is composed of three distinct domains, the substrate binding domain, the nucleotide binding domain, and the regulatory domain. The subunit contacts are between two sets of nucleotide binding domains and two sets of regulatory domains. L-Serine binds at the interface formed by two regulatory domains forming a hydrogen-bonded network between them. Serine binding induces a conformational change at the regulatory domain interfaces (4, 5) that is subsequently transferred to the active sites to produce inhibition of catalytic activity. The activity of the enzyme can be inhibited approximately 90% when only two of the four serine sites are occupied (6) , indicating that the binding of a single serine at each of the two regulatory site interfaces is sufficient to affect all four active sites.
Two distinct cooperative processes can be observed with serine binding. First, the inhibition of catalytic activity by L-serine displays sigmoidal kinetics, indicating a positively cooperative effect between subunits. Second, both positively and negatively cooperative effects are seen in serine binding to the four serine binding sites in the tetramer (6) .
Each PGDH subunit contains a single tryptophan residue (Trp-139) that is located in the nucleotidebinding domain and whose side chain is inserted into a hydrophobic pocket of the nucleotide binding domain of the adjacent subunit. Interestingly, the top of this pocket is formed by the catalytic His-Glu pair, and mutations of Trp-139 have a significant effect on the activity of the enzyme (7) . It has been suggested that this subunit-subunit contact in very close proximity to critical active site residues could form the basis for the subunit cooperativity seen in the inhibition kinetics. This manuscript explores the effector binding and inhibition characteristics of a mutant lacking an amino acid side chain at the normal tryptophan position and demonstrates that Trp-139 is responsible for maintaining the subunit association at the nucleotide domain interface. This suggests that the cooperative effects seen in native PGDH may be mediated through this interface.
MATERIAL AND METHODS
PGDH was expressed and isolated as previously described (8, 9) . Activity was determined at 25°C in 20 mM Tris buffer at pH 7.5, using ␣-ketoglutarate as the substrate and by monitoring the decrease in absorbance of NADH at 340 nm (10, 11) . Protein concentration was determined by the Bradford method as previously described (4, 12) and by amino acid analysis. All mutations are constructed in PGDH 4C/A that is a form of the enzyme where the four native cysteine residues in each subunit have been converted to alanine (4) .
Mutagenesis was performed as previously described for W139G (7) . Gel Filtration was performed with a 1.6 ϫ 216-cm column of Sephacryl S-200 equilibrated in 20 mM Tris buffer, pH 7.5, 0.2 M NaCl.
Equilibrium dialysis was performed in 500 l dialysis cartridges obtained from Sialomed, Inc. (Columbia, MD). Dialysis was performed in 20 mM Tris buffer, pH 7.5, for 16 h with 3 [H]-L-serine as a tracer in appropriate concentrations of unlabeled L-serine. Cells were sampled in triplicate and the average of 10-min counts were used to calculate concentrations of free and bound L-serine. The nominal PGDH concentration was 20 M monomer in all binding experiments. Amino acid analysis was used to determine the actual concentration.
Adair constants for W139G were determined by fitting the binding data to the Adair equation for a dimer with two binding sites (13) , expressed as dissociation constants.
where Y is the fraction of sites occupied, L is the free L-serine concentration, and K i are the stepwise Adair constants expressed as dissociation constants. Adair constants for W139 were determined by fitting the binding data to the Adair equation for four binding sites as previously described (6) . The binding data for W139G were also fit to the equation for a dimer with two equivalent and independent sites (15),
where r is the mole of effector bound per mole of protein, L is the free L-serine concentration, and K d is the dissociation constant. Coefficients of cooperativity for serine inhibition were determined by fitting the inhibition data to the Hill equation (13) .
where Y is the fractional inhibition of the activity, L is the free L-serine concentration, and n is the coefficient of cooperativity. All data were fit with the Kaleidograph (Synergy Software) curve fitting program.
RESULTS
Mutation of tryptophan 139 to glycine (W139G) produces an enzyme that is approximately 600-fold less active than the unmutated enzyme without substantially affecting its sensitivity to inhibition by L-serine. The IC 50 value of W139G is 12 M, which is comparable to an IC 50 value of 10 M for the native enzyme (see Fig. 1 ). This mutation also has a profound effect on the apparent cooperativity of inhibition as judged by its ability to alter the inhibition profile from one with sigmoidal character (W139) to one with distinctly less sigmoidal character (W139G). Analysis of the inhibition data with the Hill equation yields a coefficient of cooperativity (Hill constant) for W139G of approximately 1.2 as compared to the unmutated enzyme, which has a coefficient of cooperativity of approximately 1.85.
When serine binding was measured for W139G, it was immediately obvious that the shape of the binding 
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GRANT, XU, AND HU isotherm was significantly different than that obtained for unmodified PGDH in the same buffer under similar conditions (see below). Furthermore, attempts to fit the serine binding data to the Adair equation for a tetrameric enzyme with four binding sites failed to yield a satisfactory solution.
Gel filtration chromatography of PGDH W139G revealed that the mutation actually altered the association state of the enzyme. The Sephacryl S-200 column elution profiles of PGDH W139 and W139G (Fig. 2) showed that W139G eluted substantially later than did PGDH W139. Column calibration with standard globular proteins indicated that the approximate molecular weight of W139G was 83,000. This value is very close to the expected molecular weight of 88,000 for a dimer of PGDH subunits. In addition, the elution profile for W139G shows a shoulder on the leading edge of the peak, which indicates that there is actually an equilibrium between dimer and tetramer, but that the association is weak and the dimeric species is favored.
The analysis of L-serine binding to the dimeric W139G PGDH is shown in Fig. 3 . The plot represents the binding data fit to either the Adair equation for two binding sites (Y) or the equation that describes a dimer with two equivalent and independent binding sites (r). Table I shows the dissociation constants derived from the Adair equation for both W139 (6) and W139G PGDH. The K d values derived with the two-site Adair equation for W139G of approximately 20 M for each site compares well with a value of 21.8 Ϯ 1.5 M from the analysis for equivalent, independent sites. Thus, both fitting procedures produce essentially identical curves with equivalent dissociation constants for each site, indicating the lack of cooperativity between the two sites.
DISCUSSION
The observation that W139G retains the ability to bind and be inhibited by L-serine, but exists primarily as a dimer, indicates that the dimer is formed by the interaction between the regulatory domains rather than between nucleotide domains. This conclusion results from two observations. First, the mutation that produces the dimeric form of PGDH is found at the nucleotide domain interface and is thus consistent with the disruption of the interaction between these domains. Second, mutations of the serine binding residues in PGDH (16) showed that altering any one of them resulted in an increase in IC 50 of at least three orders of magnitude. Since the serine binding residues are contributed by both adjacent regulatory domains, breaking the interface at these domains would result in the loss of sensitivity to serine. This is clearly not the case and therefore the dimer must form through interaction at this interface. The W139G dimer retains its ability to be inhibited by L-serine at concentrations comparable to the native tetramer. This indicates that the magnitude of the inhibition at each active site is directly affected by serine binding to its own subunit. However, the cooperativity of inhibition has been lost. This suggests that this cooperativity is mediated in some way by the dimer contacts at the nucleotide domain interface, possibly through the influence of the Trp-139 side chain on the active site of the adjacent subunit.
Similarly, cooperativity between serine binding sites has also been lost. Earlier studies (6) demonstrated that the first two serines bind to the tetrameric enzyme (W139) at opposite regulatory domain interfaces. Since there is only a single interface present in the dimeric enzyme (W139G), the loss of cooperativity is consistent with this conclusion.
While this data suggests that the cooperative effects of PGDH are mediated at the nucleotide domain interface, one cannot rule out the loss of cooperativity as resulting from a major change in the orientation of the individual domains within each subunit as a result of the loss of a stabilizing structural contact at the nucleotide domains. Although the lack of change in the degree to which serine inhibits the mutant argues against this, this question will have to be addressed with a method that will allow one to assess the relative positions of the individual domains, such as X-ray crystallography analysis or perhaps distance measurements using resonace energy transfer techniques. These studies are now in progress.
The observation that a single mutation at the nucleotide domain interface of PGDH is responsible for the dissociation of that dimeric contact is surprising when one considers that the buried surface area at the interface over 1200 Å 2 . This suggests that the productive contacts between the two domains are minimal and that any others that exist may be prime candidates for additional molecular interactions that mediate the cooperative effects. This is presently under investigation. The rather fortuitous dissociation of the tetramer at this interface has served to provide suggestive evidence of its role in the cooperative processes of the tetramer, which is consistent with previous conclusions concerning the pathways of that cooperativity (6, 7) .
